🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ILSON David powers through GEJ and CRC data from ASCO for us in a clear, nuanced way: "ESOPEC is practice changing!' AdventHealth Central Florida

The force is definitely with us in Chicago. Awesome to see Mark Hamill aka Luke Skywalker at the DNC convention.

We’re fired up and ready to go! Let’s do all we can to elect Kamala Harris and Tim Walz. Join us: KamalaHarris.com

Time to move away from radiotherapy in operable GEA #ESMO24 TOPGEAR ➡️ no survival benefit when RT added to periop chemo TOPGEAR + ESOPEC : both great trials with a definitive answer = no more RT ✅Great drugs in development - let's focus on systemic Rx for cure ESMO - Eur. Oncology

Results of TOPGEAR trial indicate no survival benefit for adding radiation therapy to perioperative chemotherapy in gastroesophageal adeno carcinoma. Chemotherapy alone should be the standard of care with chemo radiotherapy only used in the nonoperative setting. ESMO 2024

Niche 2 after two doses of nivolumab and one dose of ipi and surgery. 100% of patients with MSI high colon cancer relapse free at 3 years. Arguably preop IO should be a new care standard in MSI high colon cancer.

It's a beautiful sunrise as we prepare to leave Barcelona after #ESMO24. Thanks to ESMO - Eur. Oncology Rebecca Dent Andres Cervantes Kate Kronig #ESMOAmbassadors for a super successful meeting!

I am thankful to NEJM for promoting the science presented at ESMO - Eur. Oncology Congress in Barcelona

💵 Baselined: The Biden Economy We are taking a snapshot of Joe Biden's economy before he leaves office so we have a point of comparison when Donald Trump begins to take credit for it, like he did the economy he inherited form Barack Obama.

👏 Great to see this published! VESTIGE is a negative randomised trial with an important lesson.. ➡️ Give adjuvant FLOT even when there's residual cancer after neoadjuvant chemo. 👀 Looking forward to the translational work annalsofoncology.org/article/S0923-…

Ipi nivo is the new first line SOC treatment for MSI High metastatic colorectal cancer.

Very grateful that those oncologists who inspire me to #endcancer also happen to be incredible humans! Thanks to all for coming out in SF to celebrate life and love! ❤️🌈 #GI25

Whether preparing for board certification or seeking a thorough review, don’t miss the 13th Annual Board Review and Comprehensive Update in #Hematology & #MedicalOncology this March. This intensive 3.5-day virtual course delivers an up-to-date, expert-led review. Learn more:

Thirty-two years together and you still take my breath away. Happy Valentine’s Day, Michelle Obama!

ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with HER2 Positive Metastatic Gastric Cancer at Interim Analysis of DESTINY- Gastric04 Phase 3 Trial 👉ENHERTU more effective than Pacli/Ram

We're excited to kick off the Memorial Sloan Kettering Cancer Center 2025 Update in #Hematology and #MedicalOncology and 13th Annual Board Review this Friday. Join us for an engaging program led by renowned faculty. Explore the full agenda at bit.ly/HemOnc2025. #MSKHemOncCME ILSON David,

Boston Mayor Michelle Wu is a fucking star. 🙌🙏💪👏👊👇

Mattehorn study showed EFS improvement and strong OS trend with FLOT+duravalumab. Great news to establish the global standard for fit patients with locally advanced gastric/GEJ cancer. Looking forward to the detail.OncoAlert OncoDaily astrazeneca.com/media-centre/p…